CONMED Grows on Strength of March Recovery

CONMED reported 1Q22 orthopedic sales of $107.5 million, +0.3% compared to 1Q21.

The impact of Omicron was the strongest in January and dissipated throughout the quarter, according to the company. Asian markets, particularly Japan, got off to slower starts in the quarter. Europe and Latin American markets delivered solid performances despite...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us